The Travelers Companies, Inc. (TRV)
Financieras / Seguros
One of the largest property and casualty insurers in the United States, with disciplined underwriting (combined ratio 89.9% in 2025, with $3.69bn of catastrophes embedded) and a $101.2bn float generating higher returns with elevated rates. It trades at 52-week highs at ~9×× earnings over the trailing twelve months, which are inflated by a six-month stretch of low catastrophe losses: on normalized earnings (~$7.0bn) the multiple is ~12.1×. Five-year base ~$578 (+11%/year): Undervalued.
- Price
- $367.66
- Intrinsic value (5y, base)
- $578
- Total annual return (5y)
- 10.8%
- Status (nominal)
- Undervalued
- Margin of safety
- +25%
The essentials
- Three segments of the same nature: Business Insurance (earned premiums $22.41bn, 51% of total), Personal Insurance ($17.40bn, 40%) and Bond & Specialty ($4.11bn, 9%). The sum of the three ($43.91bn) equals the total earned premiums; the difference from consolidated revenues of $48.83bn is net investment income ($3.96bn), fees ($445M in Business Insurance) and other income, not a missing segment.
- 2025 profitability was very strong despite a high catastrophe load: combined ratio 89.9% (2.6 points better than 92.5% in 2024) with catastrophe losses of $3.69bn and favorable reserve development from prior years of $1.04bn. Net income rose from $5.00bn to $6.29bn and net investment income grew 10% to $3.96bn.
- ⚠️ Trailing twelve-month earnings ($8.30bn) are not the recurring run-rate: the six-month period that entered the calculation replaced the first half of 2025, which carried the California wildfires. The model normalizes year +1 to ~$7.0bn, anchored to audited 2025 earnings plus premium growth and the company's guidance for net investment income (from ~$800M to ~$870M after-tax per quarter throughout 2026). Five-year base ~$578 → total return +11%/year: Undervalued.
Intrinsic value — two valuation methods
Total return at 5 years: 10.8%/year = 9.5% appreciation + 1.4% dividend. The target price ($578) is ex-dividend; the $30 in dividends collected over 5 years are added separately.
By both methods, the value today (DCF $900 · Multiples $490) exceeds the market price ($368).
Pillars of the analysis
The verdict — today vs 5 years
Today — fairly valued: at $368 trades ~25.0% below its value discounted to today (~$490); the discount is positive but does not reach the margin of safety we require (≥38%).
At 5 years — Infravalorado: the target price ($578) plus dividends yield above the required average return (10%) — the business compounds.
The bridge: the return at 5 years exceeds the risk-free rate (4.5%) — but the discount does not reach the required margin of safety (≥38%). To require a 15% annual return, it would need to be bought at ~$307.
Thesis
The business
Travelers is one of the largest property and casualty insurers in the United States, with disciplined underwriting (combined ratio 89.9% in 2025, with $3.69bn of catastrophes embedded) and a $101.2bn float generating $3.96bn of net investment income. Three segments of the same nature over a single balance sheet: Business Insurance (51% of earned premiums), Personal Insurance (40%) and Bond & Specialty (9%). A++ rating from A.M. Best, network of thousands of independent agents and an in-house claims organization of 12,300 people.
The valuation
An insurer is valued by the equity—earnings per share at a P/E multiple, with book value per share and ROE as controls—never by enterprise value: the invested reserves are the company's own funding, not excess cash. At ~$368 it trades at ~9×× the trailing twelve-month earnings, but that denominator is inflated: the six-month period that entered the calculation replaced the first half of 2025, which carried the California wildfires. On normalized earnings (~$7.0bn) the entry multiple is ~12.1×.
The base case normalizes year +1 earnings to ~$7.0bn, grows earnings ~4.7% per year (premiums ~3% plus increasing float returns, with the combined ratio trending toward ~92-93% as the pricing cycle softens), models a buyback reducing shares ~3.3% per year and applies an exit multiple of 12.5×, the center of the method's band for a quality insurer. That gives ~$578 per share; with the dividend (1.4% initial yield, five dollars annually after the second-quarter 2026 hike) the total return is +11%/year.
The margin of safety
It trades at a real discount to value, though short of the required margin of safety. At ~$368, at its 52-week high, the verdict is Undervalued. The return does not depend on a large multiple expansion: most comes from earnings per share growth, with the buyback contributing ~3.3% per year, and the exit multiple (12.5×) is barely above the ~11.3× paid on normalized earnings. The bear case (prolonged soft pricing cycle, a mega-catastrophe year and a 10× multiple) leaves five-year value close to today's price: downside is bounded by a recurring business and a protected dividend, but cushion is not ample. The method's discipline requires remembering that an insurer's entry point improves after a catastrophic event, not before.
What to watch
Three things. The combined ratio and the pricing cycle: pricing changes in renewal remain positive but decelerating, and a prolonged soft cycle raises the combined ratio and compresses underwriting margin. Catastrophe losses and reserves: catastrophe losses were $3.69bn in 2025 and $3.34bn in 2024, and favorable reserve development ($1.04bn in 2025) is a benefit depending on prior-year estimates continuing to prove conservative in an elevated litigation environment. And net investment income: the company guides an increase within 2026 (from ~$800M to ~$870M after-tax per quarter); a rate decline reduces reinvestment yield and brakes that engine.
Educational / informational. Does not constitute investment advice.